STATE OF CONNECTICUT et al v. AUROBINDO PHARMA USA, INC. et al

  1. November 02, 2023

    States Want Generic Drug Price-Fixing Claims Back In Conn.

    State enforcers accusing several generic drugmakers of price-fixing asked the Judicial Panel on Multidistrict Litigation to move their case back to Connecticut federal court, saying legislation signed by President Joe Biden last year spares state enforcers from the MDL process.

  2. February 27, 2023

    Drugmakers To Face Price-Fixing Claims From State AGs

    In a slew of rulings on Monday, a Pennsylvania federal court rejected most bids from drug companies seeking to nix sweeping price-fixing conspiracy allegations from a group of state attorneys general.

  3. June 07, 2022

    AGs' Disgorgement Claim Axed In Drug Price-Fixing Case

    The Pennsylvania federal judge overseeing sprawling price-fixing litigation against generic-drug makers on Tuesday tossed a disgorgement claim brought by state attorneys general, but kept alive their claim for injunctive relief.

  4. April 07, 2022

    Teva Appears Headed For $100M Price-Fixing Payout To AGs

    After last week's $1.45 million settlement with Louisiana's attorney general, a pattern is emerging in Teva's efforts to deal its way out of sprawling price-fixing litigation that could put the generic-drug maker on the hook for about $100 million if it settles with every state enforcer.

  5. December 03, 2021

    States Say AMG Case Can't Save Drugmakers In Price-Fix Suit

    State enforcers have told a Pennsylvania federal judge that this year's U.S. Supreme Court decision to pare the Federal Trade Commission's use of restitution powers has no impact on their pursuit of price-fixing damages against generic-drug makers.

  6. May 06, 2021

    Generic Drug Cos. Invoke FTC Restitution Limits Against AGs

    The potential influence of the U.S. Supreme Court decision striking down the Federal Trade Commission's claimed authority to recover ill-gotten gains in federal court continues to spread, with generic-drug makers citing the ruling Wednesday to fight state attorneys general's price-fixing claims in sprawling Pennsylvania federal court litigation.  

  7. August 15, 2019

    Drugmakers Can't Ax MDL's 'Overarching Conspiracy' Claims

    A Pennsylvania federal judge refused on Thursday to throw out allegations in multidistrict litigation that Actavis, Teva, Mylan and other drugmakers engaged in a "broad overarching conspiracy" to fix generic-drug prices, saying the allegations are sufficiently pled and discovery is needed to determine if they're true.

  8. July 26, 2019

    AGs Fire Back After Pharma Bid To End Price-Fixing Claims

    A coalition of 47 state attorneys general said Thursday that generic-drug manufacturers made "threadbare" and "irrelevant" arguments in their request for a Pennsylvania federal judge to dismiss state law claims in multidistrict litigation that alleges price-fixing among the drugmakers.

  9. June 03, 2019

    Drugmakers Want AGs' Generics Price-Fixing Claims Tossed

    Pharmaceutical companies including Actavis, Teva and Mylan have asked a Pennsylvania federal court to dismiss state law claims by 47 state attorneys general against them in multidistrict litigation accusing them of price-fixing generic drugs.